NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹277 Cr | ₹257 Cr | ₹217 Cr | ₹198 Cr | ₹149 Cr |
What is the latest Profit & Loss Account Balance ratio of NGL FINECHEM ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹277 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹198 Cr |
| Mar2021 | ₹149 Cr |
How is Profit & Loss Account Balance of NGL FINECHEM Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹277 Cr | 7.70 | |
| Mar2024 | ₹257 Cr | 18.45 | |
| Mar2023 | ₹217 Cr | 9.77 | |
| Mar2022 | ₹198 Cr | 32.69 | |
| Mar2021 | ₹149 Cr | - | |
Compare Profit & Loss Account Balance of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,010.6 Cr | 12.5% | 13.1% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 12.5% |
13.1% |
-20.8% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses